Cipla to acquire 26 percent stake in AMP Solar Power Systems Garima24 May 2019 9:30 AM ISTCipla will acquire and maintain 26 per cent stake on a fully diluted basis in AMPSolar throughout the term of the power purchase agreement, share...
Torrent Pharma posts Q4 net loss of Rs 152 crore Garima24 May 2019 9:15 AM ISTThe company had posted a net profit of Rs 228 crore for the corresponding period of the previous fiscal, Torrent Pharma said in a filing to the...
China M&A crimp due to data quality, lagging regulatory standards; says Novartis CEO Medical Dialogues Bureau24 May 2019 9:00 AM ISTNovartis has 14 medicines listed in China, including top-selling psoriasis and arthritis medicine Cosentyx, a development helped as Chinese regulators...
Zydus Cadila gets USFDA approval for Esomeprazole Magnesium delayed-release capsules Farhat Nasim23 May 2019 12:15 PM ISTThe company said Esomeprazole belongs to the group of medicines termed as proton pump inhibitors.New Delhi: Zydus Cadila has received final approval...
Biocon, Mylan gets Canadian nod for biosimilar of cancer drug Herceptin Farhat Nasim23 May 2019 11:59 AM ISTOgivri is the first trastuzumab biosimilar approved in Canada and the second biosimilar from Biocon and Mylan's joint portfolio approved in the...
Lupin launches generic version of Pulmicort Respules Inhalation Suspension Farhat Nasim23 May 2019 9:30 AM ISTLupin's product is a generic version of AstraZeneca Pharmaceuticals LP's Pulmicort Respules Inhalation Suspension, 0.5 mg/2 mL.New Delhi: Drug maker...
Cipla Q4 net profit jumps 133 pc at Rs 357.68 crore; plans fundraising of Rs 6000 crore Garima23 May 2019 9:15 AM ISTCipla has also decided to raise funds of up to Rs 6,000 crore.New Delhi: Drug major Cipla Wednesday reported over two-fold jump in consolidated net...
Novartis plans gene therapy price lower than $4 million to $5 million range Medical Dialogues Bureau23 May 2019 9:00 AM ISTNovartis has previously said it could price the treatment in a range of $1.5 million to $5 million.BOSTON: Novartis AG's top executive said on...
CDSCO rejects GSK request to skip Phase III trial for Influenza Vaccine for higher age groups Meghna A Singhania22 May 2019 5:25 PM ISTNew Delhi: One of the oldest pharmaceutical and healthcare companies in India, GlaxoSmithKline recently presented before the Subject Expert Committee...
Panacea Biotec gets USFDA nod for chemotherapy drug Azacitidine Farhat Nasim22 May 2019 9:45 AM ISTAzacitidine is a chemotherapy drug used to treat myelodysplastic syndromes (MDS) with annual sales of about USD 110 million in US markets as per IQVIA...
Alembic Pharma gets USFDA nod for Solifenacin Succinate tablets to treat overactive bladder Farhat Nasim22 May 2019 9:15 AM ISTThe company has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Solifenacin...
Merck to buy cancer drug developer Peloton Therapeutics for $1.05 billion in cash Garima22 May 2019 9:00 AM ISTMerck Inc's lead drug candidate, PT2977, will be studied in a late-stage study for treating renal cell carcinoma.New Delhi: Merck & Co Inc said on...
